NLRP3 and Salmonella Infections: Treatment with general DUB inhibitors (such as PR-619 and WP1130) has a negative effect on LPS/ATP-induced deubiquitination of NLRP3 and it also inhibits caspase-1 activation during Salmonella infection [29], which suggests that DUBs are involved in this process.